British Journal of Clinical Pharmacology 2001: Vol 52 Index

15 Pages·2001·4.7 MB·English

AUTHOR INDEX
P Proceedings. § Supplement
\ARlAOe.NvC Seol.sot p mBe|I n5t BAnLLoTAdSeN llTi,ngL . in & dyTl BOOBIS BARI RINGTON P VANMOLKQOT
ABASPD.A,, L MBOAS NVO-MU~X(O. A, CERH|O ONN,S ICDLA ., RPoDBsLs,iAb PN]D ¢ a HI BBBBAAAASVRTSROEOYUM.,X A ,N B, M | D.PN OMFA BFAOHDLE,FLN E NRSEN GES RS,Y . RJM
ABDUL-MANAP RR WEBB, |.A BBBEAECYCQOHIUG MAIAE,RM ODN.TA I, } | TLANISINIRDMAOH NA,R MD.]OT .M K BOWALGAOHNIAda.ti on K o & mMvIycNoEpRhSe.no |.0. Th
A\GABITI-ROSE] I LEFRANDT BEGAUD, B ¢ LAGNAOUL R
VHOtSSHi)TKCn.AAArDHOoLL AEzSLoOMIKlINeNII KEI,NKNN AE,.,(N MO,P E VHMK..-. .I2.R 2P}JH1K MAt3AL AaNrAdNm,GUo NkAPiISnPeK,NO.t, iEN c|sEN N,, of p R a BBEEGGdGLiGuK.,nrN,PidrI ee.n n tgrsR :a SE&KpE- ..eJPm].um,Ie A uu3Ltc 5ThE M8BRaT AAdTILRo,M (nP oe nAi KKSt]Lo, Ari Yni,tno Dgl i CJ.shM.Mt.]uoLr..fL im . b auHnTthA i&eoC nmK ilEkT ofT R BBBRROAYAJLUpREDlrEeNL oSt,Lt, eIH iSAnO, sW o|mM. eSp se :WR¢t OS( valT&W6u ue0snMAE 5 BMToEfIUf oRC r]K, EP HRROI ,EAD .T-JAOE GRJGPI AUNS A
AAAALLKL LBt-KCJI.hZE BALAeARLArRKAMUaTRLBOo,pSIWSnB ,EiEAS7 tNEN4No),N,Ir| Mi, ..n :AB N..PKH.TS.o . t C MOESt&rTR wCAiDSHTNnLAOiRCLINaE,ROIH RRADM,MA, ,E.SI pRGEaHM,rM .Ga- ..g]EiO.OnL.. H.OM.. M\ BBBEEEIILDJaJLtlNN oIsEEinNSNg:,,S AiJNcJ6.oT>. 8kH>H|, i n Eet.i ¢& VKAGRNIU UKYDEITSCZETELELRRI,E, N.| -C}MC ]h BBBBBBBBUURRRRRRCCUUUIEK1EHC)NC,GW;DEK EEHEDR,,,TR ,I H,M .mN uiDK Hn& . aT MtGiH T nHP.gO. GAKM L WRAMOeSERKaTDEs,NSA uE VErCSZeIKD,HsSE RSYL, , -TL I BE|o ,INIfL}TNK ¢ L .,IHMA N.ARLGL|RLSR ME D.N1,DM DJt
BENDSEN,] RIAHI,S
BBBBBBBBAABAAAAACAAAALAAARAAAS CACCRCCRACNANAtNtCSNLAHKKLK.LKK‘NKrhTMCTLEGTGL,-,LT.eYeM,T,-,hOMAN O,lESUrLaE A N ,OTO eu KN aINtNASXNAuYm ApNNHmM,N&,k,,DD|ANRDae1HDe, ZoGD, OJADJ. u LnJ),nNEt,]. . H..Wt.,N M trJ.M, T D. i,¢ i A ,B ADs¢ ce,E E.M s.kMN esnSLss ose] iKsRe.eJeeLeR]feee. n. , |. . H,TSd: p.TRJ .c c.rH OR see eMH GTD eA.AuXsIWY. ,E¢e E|S.IOeg GssAR V) sFIUC see.cNe4. YBe e .xA G ZG RLE O6 e e(ABNm. W)6TSHRGXOPB,iVWo kD hDOPHAO OnN,hAenNMLIEAA UESEcfN, OedJNiMcEM .eNGSNSNRTuS t cH,EGR GpT G.tc,C.oN.DS TT,Gihh,,AAe,rD, So e ADa .Ld KiM AA,n OO cSe r rRNn: G EEK XR|,MUN |m goII. I S,DRi a SlNMORZR JBP ncTeGH8 ,E UA.Nf o. Bi9B GELo Cn,QIl Sl IGROf RLaK o INmK.EPg,m.GSy MN(aG H... t T iO \ooB f&.. 1 n ,M & in BBBBBBBBBCBBOOOO OOOOBOOOUBBUBBBLIBNNBIBNBIOIORLLKLE,NXEAHEN OImGIPBHCOAEY RNLnAA,MGLNTaV hAUR RAHSAA.K.SNEC NRE.IUrIJaI C1UJTpK,MGEC,kAECIHRTJ.rMUSWQBAa,Ie O XAN.,,HI mHRtMD.M.T,UMAEr LDS aEeI ,N IETIK,A E»E,SAL nc,JE,B,P ., NstM NISS|Do.sL ,D ,e9 e.eARs¢ GEe.k O D ,. O9I . s_iM,e ND RmE]AeeP C NE .n MA.Rss.w .JM ..BeeLREeH] G .B.ixeV sAU .A. tB tKeUNU,TS,ERsE .sJHNihy.He| YAS IeI., e .SHP c s .NS OSsI eRMMMe.. s M }.Sp .DmL HB&¢DGEPO .KV h yNC E .A.,AA,SNIANB eSATo osNTVAM WBeMSM,nCNcfNJHSSONeOHRI. W H A ta OCIBAUI1FS .OHSEK RDhrtIG CUIWREFRhA, idO., ON RMe.KE,DDIANOoi RNTH]F ,.ISSaa. E»LTLINR,.|TIS,,ctlSK M KRI EQO§ eK,,e TN .T lSpIA, URPI lR REE E S d NE,ETAS iHAMYTR..dPSAs,.K.A NGNeJ.e,:O,E,(-. na . B a,C s.S Kn R. tHeI PST eh:..|pIE M x HITP B.M MNi NRO .W,n 6SK L &.J1 E I7 n\ P CCCAAAMMhRPvLarsIyPDoepdemdeBpAVUAIlDSlhcmEEcoemP&nceP3a6:AEuaPaSR rFidttRS hGTRtrGD1pLonC,reChNnoiieLaMcsM GG3AEtERmt.vHUmnaiRfJrr ua AeLeeiGaGRaG,silTrm,mUOmlE AoneNc,veR ,,ctaRmicRn reTiD. sTiRHaceZA naab A)se,GrnEtorIiaHe., Ac sZ ENAAkiReao.dbRmnNo:.FS, E. anioaO,dFilt T. el§ d. tvNn2n ] aaaRo s& .Io,adue.0s,ndE: c M&i2 gSdtr 8 5 mtvH . k4LlM 5iiya eu.AHo5,KOaa& DnsLcif, rO P sbU d .dnIcFi I s} aa.i o3Rues .|I JFMqzlp4\sl tSo. f DR Rui1o rf.aeraA FAr tS i,uOAlerP Ibq eNySsnR M IsDeit yc,fuRq aSaAcTEi.d eLo iTuQvJnrTo lrGroT,O.nLKeitoo.IiBInl eenh,EafnIrNaI 'Eompp:bEs e O Nvc(L cWwt frA,p eZ M ciyi ICof,iaoEMp Mdr to,SeIAlon KiraiSscg2Z S&( mEnP.snnl st aa,,5 , iDg.mlo,, rR i5zfi yv .Aheiua n E snoet oen.dRdAncc.fntlG ag 1dKJA G& iohee lee .r.M B.. MsetmtlMi., Ma.MsMsEmahc ybt s.:]tHe.yi oR oi,imi va.S.n& dnnnToe a U B erkiS. e1dtti2. 4h 0ne5 A0 g 0
© 200! Blackwell Science Ltd
Mtthn or iInndd ex
A POZZO, LI PARONI, R IEGRAEUWE, P.L., NIEMAN, F. &
ABIS FOR THE COTRIMO-CI ANRS I ER, A. Prec ol
ISTUDY GROUP, I
MESSOU, I ( P
AHL, M.-I ROH, H.-K 2) EUN HILLEGE, H.1
AHL, M.-l SCORDO, M.G E ZEEUV t TAMMINGA, W.]
JOHNSON ALEY-YATES, P.1 LIPWORTH DE Al ‘i | DE WOLF, M
SATHYAN, ( B,J
ADEN DALLINGER, S RAINER, G
ALLOW.N VANMOLKOT, I
| (
GRAEFI
HOON, | A.R
HOON, | PHORSSON. I
THIJSSEN, FLAW Ik KER STEIN D.. KOCISKO, DA
BOUDIER & VAN BORTI | +, WALSH, D.S
CHARLES, B.G
I WISS, 1M
VAN DER POST, |
LEFRANDT, |.D
( J CRUL,M
F.M.H. JONKMAN, |.H.G EGBERTS, A.C.G BUURMA,H
NISSEN, | SILVA, C.I FONSEKA, M.M.1) EGBERTS, A.C.G VAN
PRELUYER, J.-S SILVA, H.A.. THABREW, | PUIENBROEK, E.P
ER PATHMESWARAN, A EICHLER, H.-G RAINER, (
SAPARAMADQU, P.A.M., FONSEKA EKSBORG, S HALL. M.G
M.M.D&. D E SILVA Lack ot ELLIS, S.W. see BOYLE, J
tt ot | 1 hohi I ELSBY, R., POWELL, H., LOVATT
HELLENS, |.H.M 1 1O9P C.A.. KITTERINGHAM, N.A
t t chro DE SILVA, H_} DE SILVA, H.A HENDERSONC,. ].. WOLF, CLR. &
DE SILVA, HJ FONSEKA, M.M.ID PARK, B.K. Activities of UDP
DE SMET, P.A.G.M. see BUURMA,H curonosyltransferase and
DE WOLF, M., STOLK, L.M lutamyleysteine synthetase in
Blackwell Science Ltd Br J Clin Pharmacol, 52, 721-729
Author Index
GARDNER MEDWIN |.M CGSUNATILAKE, S.B FONSEKA
MAC DONALD, | A TAYLOR, | Y
BER MAN\ . A \ |i LEY, Pi & POWELL IR NATH ( I
KLINKHARID 1 | Ss SATHYAN, G
P BEGG, E.]
ZHANG S O
WILKS M.F., PROVAN
GEISSLINGER G GROSCH S EKSBORG,S & LI MHOLTZ
GEISSLINGER. G LOTSCH, J
CFEORGOPOL LOS M RAINER Ms t NTR
HENNI Y,M ‘ BIBBCBC INS, I I YNOLDS, FI
AH MI LLOYD,| LIA KHOO,S
Sori. BACK
AHOKOSKI ()
SIBBONS. SI (GOLDBERG M.R
CGIBBONS. S.I REYNOLDS, H.I SIMON, 1
GIBSON PALMER, }.1 JACKSON PLR
GILLEN, M.S., MILLER, B ( HAIKIN KLINKHARDT, |
P.& MORGANROTH, J. Eft R| G LEAVE F.1
PARAMESWARAN, K
OT
ASAN IR MUCK, W
BELLISSANT, I HASFORD, | SCHNEI WEISS. S
LINDHARDT,K | LH AUEISEN LEDER,
RANE, C.1 HAL SBERG LEFR AND I J.D
KSHIRSAG AR, N
HI Ay \\ |1
HEDAYE KOCH K.M
IDENI BOERSMA
HLH
M POMASKO ITMANN, J LEFRAND I }.1)
OLDBERG 1S 1) ENDERSON ELSBY IR
LEI M.DE, Ol \H R.LOWRY ENNESSY, M M¢ TI MISI K
JZHAQO Lt, Via HALPIN, 1 \
KELLEHE IR 1) ee ARKI S
KARI, ] K.P. hh
BERGIN ( MULCAHY, |} FEELY
J. & BARR Mo o
HI
HIN
HERINGS RM .C VAN DER
GOLDRING., C.E.P DODD. C.«
CORNET I \\ AN LINDEN, P.D
HERNANDEZ-DIAZ F.J GARCIA
COHEN \.1
L.A
| ( YP2 ( l
HIC KS, S.L., DAVIES, C.A., ROCKS
GORDON. SI NAISBITT, DJ
S.A., JOHNSTON, A... WINYARD,P
FARELL, |.. PIRMOHAMED, M.&
PARK, B.K. Th t Jat & BENJAMIN, N. Increas
Ss tre WOTHNIOIS follows
183 p HIGUCHI, M TAGAWA, M
GOTTLER, M SCHNEEWEISS,S HILLEGE, H.L., DE GRAEFF, P.A., VAN
FUJI, H SENDA, ¢ GRAFF, J KLINKHARDT, t GILST, W.H., VAN VELDHUISEN
FUJI, 1 TAGAWA, M GROBBEE, 1.1 HILLEGE, H.1I 1).J.. NAVIS,G ., GROBBEE, D.E. &
FUJIMURA, A HISHIKAWA, S GROBECKER, H KEES, I DE ZEED.U AccWeler,ated dech
FUJIMURA, A. see SASAKI M GROSS H S NIEDERBERGER I 1 ppn rogno stic Impact of renal
FUNCK-BRENTANO, ¢ SIMON, I LOTSCH, ]., SKARKE, C.& farcuion ind the
GEISSLINGER, G. A rapid screen benefitso f ACE inhibition: 621P
GARCIA, L.A... RODRIGL EZ, ‘ - thod : tor a single nucleotide HILLIER, ¢ PETRIE, M.¢
SNP
HERNANDEZ-DIAZ rs. a Dt polymorphism HIPPIUS, M SCHNEEWEISS, S
ABAJO, F.J. Associ mon DEV Veen ispirin MOR rt ne 714 HISHIKAWA, S., KOBAYASHI, I
stromtestnal complications GROSS, A.S. Best practice SUGIMOTO,K .-L, MIYATA,M &
ot epidennolo1 gi lrug mmno) nitvot r , 3S FUJIMURA, A. Diurnal\ inladon in the
GULLSTEN,H . see RAUNIO, H bihary excretion of fomoxc fin patients
2001 Blackwell Science Ltd BrJ Clin Pharmacol, 52, 721-729
Author index
BACK, D.]
HOGGARD, P.G
OFPFMANN, A.-K SCHNEEWEISS JAILLON, P SIMON, 1 MEADEN, E.R
AKOBSEN, P ALBERTSEN, B.K S.1 REYNOLDSH,. 1
WEBB, J.A AMES, K.P GOLDBERG, M.R MAIER, C.M
JKOERSMA, H.H JANSSEN, D BOERSMA, H.H LINKHARDT, |
MEADEN EFFERYS, D.B. 17 ATRICK, C.M_]
RAINER, G
INGHAM, N.A ELSBY, R
INGHAM, N.R DODD
DESTA, Z
WEN, X
H MEIER, C.R GRAFF, J
H., VASILAKIS-SCARAMOZZA KIRCHMAIER
XY THCKL SS. I RK, H.-t
HARDER, S
JOHNSEN, S-P
JOHNSON, TLN
JOHNSON, 7 ‘\
HODJEGAN
TUCKEI R (
WRAITH
EDSTEIN
JOHNSTON, A TAGAWA
RAHME, t
p KUMANA, ¢
AMI-FHODIJEGAN JOHNSTON, A MANA, C.R
RATT. P JOHNSTON, A WILSON,S MESSOU, I
JONES, 1 HOGGARD, P.G SCHNEEWEISS, S
ONKMAN, |.H.G. JONKMAN, J.H.G M.F.. ROSING, H
ORGA. K BUSS, N NINK, W.W., SWART
OSEPH, | RAHME, I & SCHELLENS
ZHANG, S.-Q
HUONG, DX
HUTCHINGS, A FERNER, RI KALLEN, A PHORSSON
AHOKOSKI,O
HUUPPONEN, R KAMALI, I WEBB, ].A
HVILSTED-RASMUSSEN, I RAHI
KANGAS, I AHOKOSKI, O
KANO, M TAGAWA, M HIRSAGAR, N.A GOGTAY, N.]
KARI, | GOLDBERG, M.R HWRSAGAR, N.A RANE, C.1
MANA, C.R., CHING, T.Y., KONG
KASTELIK, J.A MORICE, A.t
SENDA. (¢ KEERATITHAKUL, D Y.. MA, E.C.W., KOU, M., LEE, R.A
BEGG, E.] SUPUTTAMONGKOL, Y CHENG, V.C.C., CHIU, S.S. &
Kf ZHANG, S.-Q KEES, F.. FARBER, L., BUCHER, M
IATORE, P., CHOONARA, I MAIR, G., MORIKE, K
CLARKSON, A., PROVASI, D GROBECKER, H. |
PANDOLFINI, C. & BONATI, M rraappe tl a 1O
I 1 of ad lrug reactions
KELLEHER, D M. HENNESSY, M AGNAOUI, R., MOORE, N
KELLY,A WILLIAMS,D DARTIGUES, J.F., FOURRIER, A
KEMERINK, G.]J BOERSMA, H.H BEGAUD, B. Benzodiazepine us¢
INGELMAN-SUNDBERG, M KEMME, M.].B., BURGGRAAF, ] onsumption in the French
SCORDO, M.G SCHOEMAKER, R.D. & COHEN
IRJALA, K AHOKOSKI, © A..F. No influence of acute AMBERT, N. see BOURNIQUE, B
ITOH, M TAGAWA, M hypertrigly eridoen mpliasama t-PA in | ANCASTER, D.L. see LENNARD,I
IWATA, R TAGAWA, M healthy male volunteers: 626P | ANG, P RICHTER,¢
KERSEY, K.E. seeK OCH, K.M I ANGFORD, N.J. see COX, AR
JACKSON, D DAVIS, T.M.I KESTELL, P. see ZHOU,S I ANGFORD, N.J. see FERNER, RoI
JACKSON, P.R WALLIS, E.]., HAQ KEWN, S. see HOGGARDP,. G |t ANGLEY, R.W. see PRETORIUS, J.1
LU. & RAMSAY, L.E. Statins for KHOO, S. see GIBBONS, LEDER, U., HAUEISEN, J., SCHWARZ,
724 2001 Blackwell Science Ltd BrJ Clin Pharmacol, 52, 721-729
Author Index
LIEHR, M. & FIGULLA, H.-R
MEHWER, P VAN GINNEKEN, E.E.M
RAAIJMAKERS, F., RUSSEL, I
LEE, M.DI GOLDBERG, M.R SMITS, P. é RONGEN, G.A. A
LEE, BA KUMANA, C.R
LEFRANDT, J.D., HEITMANN, ]
SEVRE, K ASTELLANO, M
HAUSBERG, M., FALLON, M (
URBIGKEIT, A... ROSTRUP, M LtOrD: 3 GIBBONS, I
AGABITI-ROSEL, E., RAHN, K.-H LLOYD, J HOGGARD, PLG
MURPHY, M., ZANNAD, F., DI LOFDAHL, C.-G THORSSON
KAM, P.-] SMI] A. Ci LOTSCH,] GGFROSCH,S BACK
LOTSCH, J., Ml TH-SELBACH, | MESSOU., | ANGLA| RET. * ‘
PEGEDER, L., BRUNE, K JKONARD, D.,. KOUABENA, H
GEISSLINGER, G.S YOMAN 1., DOSSO, \ M
f COTRIMO-Cl
STUDY GROUP. T
ELSBY.R
HALL, M.G
BOERSMA, H.H
MANA, C.R
MACCALLUM, H WILKINSON, LB VEBB, J
MACDONALD. LA GARDNER GILLEN, M.S
MEDWIN, |.M SENDA, ¢
MAEDA, A SASAKI, M BOWALGAHA, K
AHMUIL, M Bk PEELY., f..1
1) HISHIKAWA, S
MAIR. G KEES,| PAGAWA, M
MALPAS, T.] BEGG, E.] HON, | ABAD. S
MANNINEN, P AHOKOSKI, O S DAVIS, K.R
MARTINET, M BOURNIQUE, B NTORSI, I PARONI, R
MARTINEZ, M CALAFATTI, S.A LE, N LAGNAOUI,R
MATHOT, R VAN KESTEREN rANROTH, | GILLEN, M.S
( ICE, A.H., KASTELIKJ,.A
MATSUDA, M TAGAWA, M PHOMPSON, R. Co
IEHR, M LEDER,|
MATTHEWS, A JOHNSON, TLN
1EM, H.M BOERSMA, H.H
LILJA, J.J DESTA,Z MAXWELL, S.R MCENIERY, C.M KE, K KEES, I
MCCOLM, | VANMOLKOT, I ARIS, A.D BUTLER, R
ILLEYMAN, J.S LENNARD,I
MCDONALD, ].I PETRIE, M.¢ RTON, J.J PETRIE, M.¢
ILLEYMAN, J.S LENNARD), I
MCDONNELL, B ALLEN, D.] MISE, K M. HENNESSY, M
LIMMROTH, V. & MICHEL, M.C. I
MCENIERY, C.M WILKINSON ULY, S. & PAINE, M.F. Ef
MCENIERY, C.M., WILKINSON, LB
MAXWELL, S.R. & WEBB > (
LINDHARDT, K., GIZURARSON, S$ MUCK, W., NEAL, D.A.J., BOLX, O
VOIBT.,H HA,SAN , RL &
STEFANSSON, S.B., OLAFSSON
D.R.& BECHGAARD, I egulau +88P ALEXANDER, G.J.M. Tacrolu
I MCLACHLAN, A_] NATH, C.1 hor
MCMURRAY, ].[.NV PETRIE, M.( )
MEADEN, E.R HOGGARDP,. G MUCKLOW, J.C. Adverse dru
to Nealth duntect MEADEN, E.R., HOGGARD, P.G., 4(,|
LIPNICKI, D.M. see DRUMMOND, P.D CHANDLER, B.. KHOO,S.H.& MUCKLOW, J.C. Continuing
LIPWB.JO. & RDALTEY-YHATE,S, P.1 BACK, DJ. Expression of the etHux Education in Cli
Systemic bioavailabilty of ters P-gp ind MRP in Caucasian Therapeutics
proprionate: 45 k African healthy volunteers and
LIPWORTH, B,J. see FOWLERS,. J HIV intected Caucasians: 481P MULCAHY, F. see M. HENNESSY, M
LIU, M.-H., FLOST.HE., NYAN,G, Q. & MEIER, C.R., SCHLIENGER, R.G. & MULDER, W.M.¢ ¢ RODER, |
HE, G.-W Inhibitioont JICK, H. Use of selective serotonin MULDER, W.M.C., MEINARDI,
VaASOCONSTIIC tion by AJ-2615, a nove reuptake inhibitors and risk of M.M.H.M. & VAN BOXTEL,
2001! Blackwell Science Ltd BrJ Clin Pharmacol, $2, 721-729
Author Index
PARK, B.K ELSBY,R
PARK, B.K GORDON, Sf
PPPAAARRRKO,KN ,I, k K RC..-.S WSIALRLLOOINAHIMA,S,, DAH... - K LE\ PROVALNTT,A ST , TADWYD .AMK AMIEMEP,IH ACLCLI,§ ATOMR.EG. , P
POZZO, L.F., CIGHETT]I G PUTTAMONGKOL,Y
NNNAA'IIDSSRBBTIIIHTT--TTY,,S O EMLABDDA.N ]C, H , W1IG L| OLRIDAMOMESNSL,S,OO T U.S,DC SHJ}, I | iCMn—tOiO ptLeoN r OTMOBROS,If ,op fhR F.at r.o ,t‘E h fRe IraGpAy TkId Ter It f.o o P turin | VIAMET,M SAOKNEE.,, R SJ,1O D JNS.S EIAP I&H D,-LL 1EM. LE,OIR EIKERORN,.G ,, P SJ.. (X
NATH, C.E., MCLACHLAN \.]
rUNNING, R PARR Y-BILLINGS. M
*~ATEL, N LENNARID K.HG. , KISSL, EFBR., ANDDATL,L INGLDE R. S
-“ATHMESWARAN. A DL. OO. GEORGOPOULOS M
H.A
NNIE UAlV| ODN.EA.NJ MJ UCK,D ESWVvT A,Z P, EAAXRTSOONN., LWH DZAHVOIUS.. KS. R ‘.. AGHLE MICE(H TLTEREM,ER NEARPH .A-CGE | , R., POLAK
NEUVONEN, P WEN, X EASTON, R CAMIDGI IR
NEWMAN, S.P. & CHRYSTYN. H -ECK, R VANMOLKOT, I
-EDRAZZOLIIR, | CALAFATTI
‘
NNNIIEEEWSMDTUAUEONPPRN,UUB, TTE TRTIA GAPME.MNOR O.NDN GE GK|KOW LOOL.!F , GROM\ SCH. § --EENM\L NEKI\E ONGGENN-E,VN A,N©- .E.,B sEeREeSO RTSA.EU NNDIAFO.]A..AI .. H VFARN RAMANSEN.A,J. .Y . CS.H7A H,L ID ALPV.1I ,J ACS\ K.SSK.OS,NH ,)I GROSGPTA.RAG YA R
NISSEN, L.M., TETT, S.E.. CR AMON] STRICKER, B.H.( 1) ‘ A,
l'., WILLIAMS, B. & SMITH. M.1
AMEESORAJ.M
PETRIE, M.C., MCDONALI
S<UPUTTAMONGKOL. \
HILLIER, C.. MORTON NIO, H., RAUTIO. A
NOORDZIJ. LAY VAN DER MCMU, RRAY, I|.J. -V. Effeets ot GULLSTEN, H. & PELKONEN
P; OST, : ] -
NOUYRIGAT. | SIMON, 1 rT ms of CYP2AG6
ees segs
OOHK, A1MDU.-RY A NR OH, THA.G-AKW A. M ) HLII PP,p ws: TH 165 \W ENZEL7 , etic RR.RR ] AYMLOON.D .A | RAUVNAINQ O.K ESH TEREN
OOLLAAHF,S SORN., LOWD.RR.Y sseeee LGINODLHDABREDRT,G K sh,I aIc EroTs|Er nRabSa X,S, Ss NM Aep Ms .S.N 1 PRI e\ o\N 2 IDLIESDRE R .tP POO ST BOTEERLSMIAN,G SPEH.RHG ER P.M
OOOOORRLUOTRS-SI.EYTZ NAE,.N RLGH«, RU1. HIA S.MD,..- SF.O rBWs OeLFeEseTe R.LI.C_U.AT H LA AMFS7AM|T- IT0NI ,G A,S .A W.] PIIRRLRLMMAMnYdOO, O HHHpAAhAaDMMM.r EEmEsaDDDec,.,oeg eHnOoMMMm.. G icGPsh:Asee a GDRrOmODaR3 cD.PD+o>D Og( e,N n ', et icC.«s S I REEYYS.NEN..O OILL DDKSSH,,O OP,RHH E.ILE SU.YHE. R¢ J&,IG A I,B BJABJ.CO.F-KN.M .S ,G IBI BONS
PIRMOHAMED, M. see WILLIAMS.D
PAINE, M.F. see MOULY, § "LEASANCE, S. see PALMER, J. IS/MS for
PPAAKLBMIEERR,S , J.L.,M .T.S COTsee T.B OERR..S. MAG,I BSHO.NH ‘-OOILRAKI,E R, K.J s.Me.e s ReAeIN SEIRM,O N, G 1 RIAHI, S.o.rm gF sOeNrAvGicEeR:. 48K1 P TOFT, I
P<AA(4=.n , 5 0Y= PDi pInrCteKorIbaNecS tii.son undb smtMir.abdet&twae sz oPln aLcmEhth lAeo Sr(AzcCyoN YxCaaPEz3io.An a ,S PP--OOOOOPNWPUWSEE,LE,L TL LELR,G, ,K . AR.H. .¢ NJ.. Ts sseee Reseee EeEDL LWSEGBUI YAHLY.ROS EODORNNNR,,E. RJ .S NJ.-.M ].M NHBOoV FrIEt1TLh-elS,NroTnw H eEDr.DJi un-&JtSg lR. adSn,AdrE SO,Ju MOgRNDHsUe ENSnSd,SmNuEaErSrNiN kn.E:.g NH1S,.39.I0P9 7.U1 .s -e98 o f in
PPPPAAAARLNRKeFpMD.,v AEEaO. lMRuLua,aEFtBte T.IeS Kh N.eW IPAa..ussAR et hseeA maDNo( fO ,i Dsm Dpeu,dRt iKuUI m.ML C &Pw,.c i«eIMo lnHC ls: AC IRcoAG1u2TnR]t OEs RAItVo I PPRREAcTBLMlOTEoRARzTDIANaWpU,DGiPSI n,SL.Ne EH, a sYAeJne .J,WdLH.. ,,U Mh N aRP.TW.,lH, CI So.ML SpZL.CIeAJoP rmBSpoiA.anr dDi sosLMoo.lm .nI,e of& RRRIIICECSCwHPTH .e,I UTHi,CgEL WhRHItB,,N . E GMh.,e¢ Rp .Ia rseieA. E.nTxS- KcKI.rHiO neTZ .CtZih,HsoueM, EnHme ASUa nNCoCLKf HHN..NlMm,oi, EJwl Ak .E:. ,Wm oE&L7lI0Ae 8cNS uGSl.a.r
tutonomic and psychomotor functions. RIGATTI, P. see PARONI. R
726
200! Blackwell Science Ltd Br J Clin Pharmacol, §2, 721-729
Author Index
RILEY, P.H GARDNER-MEDWIN SCHAFERS, R.I WENZEL, R.R SIMS, E.J. see FOWLER, S.]
}.M SCHEININ, H AHOKOSKI, O SINGH, S.D ALLEN, D.J
ROBIEUX, | PORFFOLI, G SCHELLENS, ].H.M CRUL, M SITZMANN, | RICHTER,¢
ROCKS, S.A HICKS, S.1 SCHELLENS, J.H.M. see KRUTPTZER SKARKE, ¢ GROSCH, S$
RODER, E., MULDER, W.M.¢ C.M.1 SMIT, A.J LEFRANDTJ,. D
MEINARDI, M.M.H.M. & VAN SCHELLENS, J.H.M VAN SMITH, A.J. TI usiness of
BOXTEL, C.J. Reproducibility KESTERENC,h ) ory of Grlaxo: 46 )
SCHLIENGER, R.G MEIER, C.R SMITH, M.1 ¢ NISSEN, L.M
SCHMETTERER, | RAINER,G SMITS, P MEIER, P
148/80: 624P SCHMIEGELOW, K ALBERTSEN SNELL, P BUSS, N
RODRIGUEZ, S GARCIA, L.A B.K SONNIER, M RELUYER, |.-M
ROH, H.-K.. CHUNG, J.-Y., OH, D.-¥ SCHNEEWEISS,S ., GOTTLER,M SORENSEN, H RIAHI,S
PARK, C.-S., SVENSSON, ].-O HASFORD, J.,. SWOBODA, W SORENSEN, I POFT, H
DAHL. M.-L. & BERTILSSON,I HIPPIUS, M., HOFFMANN, A.-K SORIO, R PORFOLT, G
P Ol tratofi haolonpersid o RIETHLING, A.-K. & KRAPPWEIS SOUKHOVA, N DESTA, Z
|. First results trom SPINA, I SCORDO, M.G
STACHULSKI, A.\ ROW, I
STALLARD, N WHITEHEAD), |
RONGEN, G.A MEHER, P SCHOEMAKER, R.D KEMMI STEFANSSON, S.B LINDHARDT, K
ROSENDAAI R PENNING-VAN M.}.B STOLK, L.M DE WOLF, M
BEEST, F.J.A SCHRODER, H ALBERTSEN, B.K STOLK, L.M.K BOERSMA, H.H
ROSING, H KRUTTZER, C.M.1 SCHROR, K WEBER, A.-A STRICKER, B.H.Cl PENNING
ROSTAMI-HODJEGAN, A YANG SCHWARZ, G LEDER, | VAN-BEEST, F.].A
1S SCHWIPPERT, B WEBER, A.-A STRICKER, B.H.4 VAN DER
ROSTAMI-HODJEGAN, A BOYLI SCORDO, M.G., AKLILLU, E., YASAR LINDEN, P.D
J U., DAHL, M.-L., SPINA,E . & STRICKER, B.H.C]I VOORDOUW
ROSTAMI-HODJEGAN, A HUNT INGELMAN-SUNDBERG, M ACG
STRUNHKER-BOUDIER, H.A,] DE
S.J Cc tic polymorphism Of CVTOCHT«
ROSTAMI-HODJEGAN, A P450 2C9 in a Caucasian and a black HOON, ].N.].M
STRUTHERS, A.D BUTLER, RK
JOHNSON, T.N Atrica popu non $47
ROSTAMI-HODJEGAN, A WEBB, SCOK.,T COTLLI,NS, R.. & FEELY. STURKENBOOM, M.C.J.M VAN
J.A J. Does nerease in dietary salt aft DER LINDEN, P.D
STURKENBOOM, M.C.).M
ROSTAMI-HODIJEGAN, A odium hthium counter-transport
VOORDOUW, A.C.G
1S SLC)?: 468P
ROSTRUP, M LEFRANDT, J.D SCOTT, R.J. see PALMER, J.1 SUGIMOTO, K.-I HISHIKAWA, S
SUPUTTAMONGKOL, Y., NEWTON
ROUTLEDGE, P.A FERNER, RI CRUL, M. see CRUL,M
ROW, E., STACHULSKI, A.V SEIVEWRIGHT, N HUNT, S.] P.N., ANGUB.S, T,EJ A
JOHNSON, TLN.& LENNARD, M.S SENDA, C., YAMAURA, Y ISAVADHARM, P
KEERATITHAKUL, D..,
Fruit juices andr ed wine1 KOBAYASHI, K., FUJII, H..
Intestl ind hepatic cytochrome P450 MINAMI, H., SASAKI, Y RASAMEESORAJ, M
PUKRITTAYAKAMEES., & WHITI
CYP3A: 475P IGARASHI, T. & CHIBA, K. Influence
N NJ. A comparisoonf oral artesunate and
RUSSEL, I MEIJER, P of the CYP2D6*10 allele on the
mether antimalarial bioactivities 1n
RUTHEMANN, ] WENZEL, R.R metabolismo f mexuctine by Numa!
icute falciparum malaria: 655
microsomes: LOO
SVENSSON, J.-O. see ROH, H.-K
SABIN, ¢ HOGGARD, P.G SENEVIRATNE, S.1 FONSEKA
SWART, M KRUIJTZER, C.M.1
SAKAMOTO, K SASAKI, M M.M.1)
SALES, S HOGGARDP,. G SETO, W.-H. see KUMANA, C.R SWART, M., see CRUL, M
SWOBODA, W. see SCHNEEWEISS, S
SALMINEN, I AHOKOSKI,O SEVRE,K . see LEFRANDT, J.D
SZABADI, E. see PRETORIUS, J-1
SHAH, P.l e RANE, C.1
! SALMON-CERON, D ABAD.S
SALONIA, A. see PARONI, R SHAW, P.]. see NATH, C.E
SAPARAMADU, P.A.M. sce DE SILVA, SHENFIELD, G.M. Therapeutic drug PAALIKKA, M. see AHOKOSKI, O
y H.A monitoring beyond 2000: 3S TAGAWA, M., KANO, M., OKAMURA
SASAKI,H . see TAGAWA, M SHENFIELD, G.M. Therapeutic drug N., HIGUCHI, M., MATSUDA, M..,
SASAKI, M., MAEDA, A., SAKAMOTO, monitoring: Introduction: IS MIZUKI, Y., ARAI, H., IWATA, R.,
K. & FUJIMURA, A. Effect of bile acids SICARD, D. see ABAD,S FUJI, T., KOMEMUSHL S., IDO, T..
on absorption of nitrendipine in healthy SIMON, T., BECQUEMONT, L., ITOH, M., SASAKI, H., WATANABE,
HAMON, B., NOUYRIGAT, E.., T. & YANAI, K. Neuroimaginogf
subjects: 699
SASAKI, Y. see SENDA,¢ CHODJANIA, Y., POIRIER, J.M., histamine H,-receptor occupancy 1n
SATHYAN, G., CHANCELLOR, M.B. & FUNCK-BRENTANO,C . & human brain by positron emission
l GUPTA, S.K. Effoef OcROtS* JAILLON, P. Variability of cytochrome tomography (PET): A comparative study
controlled-release delivery on the P450 1A2 activity over time in young of ebastine, a second-generation
pharmacokinetics and ind elderly healthy volunteers: 601 intihistamine, and (+
pharmacodynamics of oxybutynin SIMONIAN, S. see VOORDOUW, chlorpheniramine, a classical
chloride: 409 A.C.G antihistamine: 501
727
© 2001 Blackwell Science Ltd BrJ Clin Pharmacol, 52 . 721-729
Author Index
TAMMINGA, W.}., WEMER, | HUANG, S.-M. Opumising VAN VELDHUISEN, D.J. see HILLEGI
OOSTERHUIS, B., DE BOER, A levelopment H.1
VRANCKX, S., DRENTH, B.F.H ibolismi/ tra ANMOLKOT, F., DE HOON, |
DE ZEEUW, R.DAE .LEI,], L.F.M.H potential—towards a consensus: 107 BARRINGTON, P., PECK, R
& JONKMAN, J.H.G. Th 1 PWISS, 1.M., BURGGRAAF, }., DI DALLOW, N., WILLIAMS, P. &
KAM, M., COHEN, A.F. & VERMEI] MCCOLM, J. Ass nent of peri
CYP2D¢ P. Difference i trointestinal (Gl 9S-HT ,
AN. H CRUL, M
ANIRA, M.O.M., AL-NAZWAN, N ANT VEER, L.] CRUL,M
AL-BARWANI, H., AL ZAABI, M.A URBIGKEIT, A LEFRANDT, J.D ASILAKIS-SCARAMOZZA, (¢
<«B AYOUMI, A.L. Pharmacogeno WOK. H
vt OC) VAN AMELSVOORT, 17 ASS ( RAINER,. G
COMPTON, | VERMEL], P PWISS, 1M
CYP2ZD ( s: 455P VAN BORTEL., L.M.A.B DE HOON OTH, B MUCK, W
AYLOR, ].Y GARDNER }.N.J.M RDOUW, A.C.G., VAN DER
MEDWIN, |.M VAN BOXTEL, ¢ MULDER SIMONIAN, S., VAN
EGEDER, | LOTSCH, | W.M.¢ |...S FURKENBOOM
EJA-ISAVADHARM, P VAN BOXTEL, C.] RODER, I & STRICKER, B.H.«
SUPUTTAMONGKOL, ¥ VAN DEN HOFF, O.P BUURMA,H
BOKKEL HUININK, W.W VAN DER LEI, J VOORDOUW
KRUIJEZER, C.M.f ALG
rer. $3 NISSEN, L.M VAN DER LINDEN, P.D 5p
THABREW, | DE SILVA, H.A STURKENBOOM, M.C.|.M TAMMINGA, W
HIISSEN, H.H.W DE HOON HERINGS, R.M.C., LEUFKENS GOLDBERG, M.R
|.N.J.M H.M.G STRICKER, B.H.¢
THIMISTER BOERSMA |
HLH \
HOMPSON,. R MORICE, A.H JACKSON, PLR
HORSSON, I DSBACKER. S P EDSTEIN, M.D
Kp ALLEN, A LOFDAHL, C.-G VAN DER LINDEN, P.G WEN
VOORDOUW, A.C.G A TANABE. 1 TAGAWA, M
Diskus’ {pMDI VAN DER POST, |.. NOORDZI] \TKINS, ¢ HUGHES, A.M
Pus L.A.W., BLAUW, G.]., DE KAM TSON. DJ RAHME, I
TINGLE, M.D ZHOU,S M.L., PIETERS, M.S.M., COHEN 1] MCENIERY, C.M
PyIA,J GIBBONS, I A.F.& VAN GERVEN, J.M.A 1D] WILKINSON, LB
PIA, J.1 REYNOLDS, HI (
s DJ WILKINSON, L.B
LQODD.S WHITEHEAD, | as imp ‘ 5p VEBB, J.A.. ROSTAMI-FHODJEGAN
LORFG.O. CLORIONA,, G.. SORITO VAN GERVEN, |.M.A FRANSON
ABDUL-MANAP, R
RK.. ROBIEUX, L, BASSO, B K.1
HOFMANN, | MIKUS, G. &
COLUSSI, A.M. & BOLOCCHI, M VAN GERVEN, J].M.A VAN DER
KAMALI, F. Cont
Poy POST, |
VAN GILST, W.H HILLEGE, HI
VAN GINNEKEN, E.E.M MEIJER, P
ko ae RIAHI,S VAN GROOTHEEST, K VAN
PORT, H RIAHI,S PUTENBROEK, E.P
VEBER, A.-A., BRAUN, M
PORT, H., SORENSEN, I VAN HEERDE, W.1 BOERSMA
MELLEMKJAER, |.H.& OLSEN, |.H H.H HOHLFELD, T.. SCHWIPPERT,B
IR VAN KESTEREN,C h., MATHOT ISCHOPE, D. & SCHROR, K
rn
R.A.A.. RAYMOND. E., ARMAND
).P., BEIPNEN, J.H. & SCHELLENS
}.H.M. DD
TOMASKQO, D GOLDBERG, M.R VEITZEL, H RICHTER,¢
PRELUYER, J.-M., REY, E., SONNIER WEMER, } TAMMINGA, W.]
M.,{ PONS, G. & CRESTEIL, 7 tudy: 618k WEN,X ., WANG, J.-S... KIVISTO, K.1
VAN MEEGEN, I ¢ PENNING-VAN NEUVONEN, P.J. & BACKMAN, J.1
BEEST, F.J.A f valuation of valproic acid as an
ISCHOPE, D WEBER, A.-A VAN PUITENBROEK, E.P., VAN ot human cytochrome P450
TUCKER, G. BJCP — Down under GROOTHEEST, K., DIEMONT forms: preferential inhibition ot
PUCKER, G.1 BOYLE, | W.L., LEUFKENS, H.G.M. & ytochrome P450 2C9 (CY P2C9): 547
PUCKER, G.1 JOHNSON, TN EGBERTS, A.C.G. Determinantost WENZEL,R .R., RUTHEMANN, J.,
TUCKER, G.I YANG, J.S wWhal seiectiol tspontaneous BRUCK, H., SCHAFERS, R.F.,
PUCKER, G.1 YANG, |S reporting system for adverse dru MICHEL, M.C. & PHILIPP, TH
PUCKER, G.1 HOUSTON, J.B. & Endothelin-A receptor antagonist
728 2001 Blackwell Science Ltd Br j Clin Pharmacol, §2, 721-729
Author Index
inhibits angiotensin I] and noradrenaline WILLIAMS, B. see NISSEN, I role interacuion with midazolan
in man: 151 WILLIDA. &M FESEL,Y, ] nd triazolam: incorporating population
WESTRUP, D KLINKHARDT, | condary prevent nlity: 484P
WHITE, N.] SUPUTTAMONGKOL, evidence for the yentyl YANG, J.S.,. ROSTAMI-HODJEGAN, A
Y ndrome: +70P & TUCKER, G.T. Predictioont
WHITEHEAD, A WHITEHEAD),| WILLIAMS,D ., KELLY, A. & FEELY
WHITEHEAD, J, ZHOU, Y J. Preferential |
STALLARD,N., TODD,S
WHITEHEAD, A. Learning tron hildren: 31! $7_21
YANG, Q
previous responses 1n phase | dose WILLIAMS,D ., NAISBITT, D ¢ LIU, M.-H
PIRMOHAMED, M. & PAI YASAR, | SCORDO. M.G
WHYTE, 1.M DAWSON, A.H Cytotoxic and apoptot YEO, K.R & YEO, W.W. Lipid
WILEY, K.E. & DAVENPORT, A.P
in peripheral white cells: 477P
Function | | WILLIAMS, K.M. sce CAMPBELL, 1 England 1998: 486P
WILLIAMS, P. see VANMOLKOT, I YEO, W.W. see YEO, K.R
WILSON, A.M FOWLER, S.J
tl ( isodilators: 4+78P
WILSON, K ALLEN, D.] ZANNAD, I LEFRANDT, |.D
ILKINS, I HOGGARD, P.G WILSON, S., JOHNSTON, A., ZHANG, S.-Q., HAI, T.N., ILETT, K.1
ILKINSON, LB. & WEBB, D.J. Venous COLLDI.,E FERDE,R, G HUONG, D.X., DAVIS, T.M.E. &
oO USION plethysmorrapny 1 POULN.,T CAEULFRIE,LD, M ASHTON, M. Mult
Recruitment to clini trl Lox
WILKINSON, LB MCENIERY, C.M nfluence response 1O8P ; ZHAO, | GOLDBERG, M.R
WILKINSON, I.B., MCENIERY, C.M WINYARD, P HICKS, S.1 ZHOU, H.-H LIU, Z.-Q
BONGAERTSK,.H ., MACCALLUM WOLF, C.R. sce ELSBY, R ZHOU, S., CHIN, R., KESTELL, P
H.. WEBB, DJ. & COCKCROFT WOLZT, M RAINER, G TINGLE, M.D. & PAXTON, J.W
J... Adrenomedullin (AIDM WRAITH, I JOHNSON, T.N
YAMAURA, ¥Y SENDA, (¢
oO YANAI, K TAGAWA, M LDMSAA
NH } YANG, |.S.. ROSTAMI-HODJEGAN, A
WILKS, M.I HALI PUCKER, G.T. Prediction of ZHOV, Y WHITEHEAD, |
© 200! Blackwell Science Ltd BrJ Clin Pharmacol, 52, 721-729